Doctor Sara Chiaretti

A photo of Sara Chiaretti

Dr Sara Chiaretti

Research Fellow
Product Safety 

Adjunct Fellow -University of the Sunshine Coast, Adjunct Fellow-The University of Queensland

Connect with Dr Chiaretti
Email LinkedIn Research Gate

Sara specialises in erythropoiesis and neonatal transfusion research, with a focus on developing cord blood-derived products to improve care in neonatal intensive care units. She collaborates with hospitals across Australia to enhance paediatric transfusion practices.

With a PhD in Experimental Medicine and Oncology and over 15 years of experience in cell biology and therapeutic development, Sara brings deep expertise from both academic and industry settings. Sara is also a member of the ISBT Clinical Transfusion Working Party, contributing to its paediatric subgroup. Her work bridges scientific research with clinical application, supporting the mission to deliver impactful healthcare solutions.

Leadership
  • ISBT Working Party Clinical Transfusion – Paediatrics subgroup
  • Member of International Society of Blood Transfusion (ISBT)
  • Member of Australia & New Zealand Society of Blood Transfusion (ANZSBT)
  • Member of Association Italian Researcher in Australasia
  • Supervisor of PhD, Master and Honours students

     
Awards
  • Reviewer of the month-Annals of Blood

Key publications

Human neutrophil antigen 3 genotype impacts neutrophil-mediated endothelial cell cytotoxicity in a two-event model of TRALI
Chiaretti S, Burton M, Hassel P, Radenkovic F, Devikashri N, Sultana AJ, Temple FT, Dean MM, Tung JP
2022
Blood Transfusion
20(6):465-474
View publication
Transfusion-related acute lung injury (TRALI): Potential pathways of development, strategies for prevention and treatment, and future research directions
Tung JP, Chiaretti S, Dean MM, Reade MC, Fung YL
2022
Blood reviews
53:100926
View publication
Recovery of organ-specific tissue oxygen delivery at restrictive transfusion thresholds after fluid treatment in ovine haemorrhagic shock
Dyer WB, Simonova G, Chiaretti S, Bouquet M, Wellburn R, Heinsar S, Ainola C, Wildi K, Sato K, Livingstone S, Suen JY, Irving DO, Tung JP, Li Bassi G, Faser JF
2022
Intensive Care Med Exp
10(1):12
View publication
*Effects of the scaffold proteins liprin-α1, β1 and β2 on invasion by breast cancer cells
Chiaretti S, Astro V, Chiricozzi E, de Curtis I
2016
Biology of the Cell
108(3): 65-75
View publication
*Liprin-α1 and ERC1 control cell edge dynamics by promoting focal adhesion turnover
Astro V, Tonoli D, Chiaretti S, Badanai S, Sala K, Zerial M, DeCurtis I
2016
Scientific Reports
6(1): 1-16
View publication

* This research was completed prior to starting with Lifeblood